Equipment at MOMA

MOMA staff 2022
Modern and spacious laboratories
Genetic Diagnostics by NGS
Traceability is part of quality assurance
Automatisation by robots
DNA Diagnostics
Processing of blood samples
NGS Core Center since 2012
NGS Core Center - Send your request!
ctDNA analysis
Bioinformatic data analysis
Cell cultures
Fluorescence microscopy
Immunohistochemistry
Colon adenocarcinoma cells

This is a comprehensive but not complete list of instruments and equipment at MOMA.
If you are interested in collaborating projects, please contact our staff.

DNA, RNA and Sequencing

2 x ABI 3500XL Genetic Analyzer

Illumina NGS sequencers: 2 x NextSeq 500, 2 x MiSeq, NovaSeq

ABI 7900, VIIA7 and Quantstudio 12K Flex RealTimePCR systems

Biorad Droplet Digital PCR

Biorad PCR C1000, S1000 and C1000 Touch

Nanoquant infinite

Agilent Bioanalyzers

QiaCube

LabChip GX and Tapestation

UVP DigiDoc and Chemidoc systems

Covaris DNA shearing

Automation

Sciclone NGS workstation

Zephyr NGS workstation

Qiasymphony

Perkin Elmer NGS express

Biomek

Cell Culture and Histology

Arcturus Laser microdissection system

Roche XCELLigence system

Cedex cell counter

Microtome

Microscopes: light and Axiovert fluorescense

Nanostring GeoMx

Proteins

Western Blot system

Chemidoc UVP

Biotek Fluorescence /Luminiscence Reader

Multiscan MCC 339

Current Research Networks and Large Projects

Effects of Germline Structural Variation on the Biology and Pathology of the Large Intestine (2021-2024)

CIRCPAC – A National Randomized Trial Investigating the Clinical Benefit of circulating tumor DNA Guided Recurrence Surveillance After Resection for Pancreatic Cancer (2020-)

UTILITY - Using liquid tumor biopsies & genetic testing to guide personalized treatment of advanced prostate cancer: From discovery to clinical care. (2020-)

TOMBOLA - Treatment of Metastatic Bladder cancer at the time of biochemical reLApse following radicial cystectomy (2020-)

DCCC ctDNA Research Center - Danish National Center for Circulating Tumor DNA Guided cancer Treatment (2020-)

DCCC Danish circulating tumor DNA network (DCCC ctDNA) (2019-)

NorDCaP - Nordic Implementation of Personalised Prostate Cancer Diagnostics (2019-)

PRIMA - Early and accurate detection of prostate cancer in general practice (2018-)

IMPROVE - Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer (2018-2025)

IMPROVE-IT - Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer (2018-2025)

IMPROVE-IT2 - Implementing noninvasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer – intervention trial 2 (2018-2025)

"Individualized monitoring of cancer by deep sequencing of circulating tumor DNA in patients with advanced bladder cancer "(2017-)

PROCARIS - A new strategy to prevent overdiagnosis and overtreatment of non-aggressive prostate cancer in the aging male population (2016-)

PAGER - Analyzis of personal genomic rearrangements for surveillance of patients with bladder cancer (2013-)

OPRA - Oncology Precision Medicine Project Aarhus (2017-)

NEXT - Danish study of personalised cancer therapy based on tumor genetics (2017-)

""Early detection of recurrence and more curative therapy for colon cancer patients" (2016-2020)

PanCancer Analysis of Whole Genomes (PCAWG) Project (2015-)

Research Groups at MOMA

Bladder Cancer Group (Lars Dyrskjøt)

Colon Cancer Group (Claus Lindbjerg)

Prostate Cancer Group (Karina Dalsgaard Sørensen)

Medical Research Group (Claus Gravholt)

Bioinformatics Groups: